BCAL Early Cancer Detection Tests Update
Filed with ASX · · 4 pages · English
BCAL Chief Executive Officer Shane Ryan said: “Our partnership with ClearNote Health is transformative as it expands our portfolio into the early detection of multiple cancers. The Australian medical community will benefit from a suite of early diagnostic tests that will materially improve outcomes for patients. “ClearNote’s recent global achievements, including UK regulatory approval, selection f
BCAL Diagnostics Limited on 6ix
Story so far
Earlier from BCAL Diagnostics
- BCAL Establishes $10m Convertible Note Facility Revised
- BCAL Establishes $10 million Convertible Note Facility
- BCAL and ClearNote Partner on Early Cancer Detection Tests
- Appendix 4E and Annual Report
- BCAL Partners with Sonic Healthcare
Later from BCAL Diagnostics
- Quarterly Activities/Appendix 4C Cash Flow Report
- Shareholder Update
- Half Yearly Report and Accounts
- BCAL Accelerates Rollout of Avantect Early Detection Tests
- BCAL Appoints Anne-Louise Arnett as Chief Executive Officer
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics